{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:14:51Z","timestamp":1771316091802,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,16]]},"DOI":"10.7759\/cureus.103751","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T07:42:00Z","timestamp":1771314120000},"source":"Crossref","is-referenced-by-count":0,"title":["When Foot Drop Tells a Bigger Story: POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Plasma Cell Disorder, and Skin Changes) Syndrome Revealed by Femoral Plasmacytoma"],"prefix":"10.7759","author":[{"given":"Usamah","family":"Al-Anbagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safwan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussam","family":"Telfah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mohamedali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulqadir J","family":"Nashwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome","volume":"21","author":"Dispenzieri A","year":"2007","unstructured":"Dispenzieri A. POEMS syndrome. Blood Rev. 2007, 21:285-99. 10.1016\/j.blre.2007.07.004","journal-title":"Blood Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.10.007","article-title":"POEMS syndrome: real world experience in diagnosis and systemic therapy - 108 patients multicenter analysis","volume":"22","author":"Jurczyszyn A","year":"2022","unstructured":"Jurczyszyn A, Castillo JJ, Olszewska-Szopa M, et al.. POEMS syndrome: real world experience in diagnosis and systemic therapy - 108 patients multicenter analysis. Clin Lymphoma Myeloma Leuk. 2022, 22:297-304. 10.1016\/j.clml.2021.10.007","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301706","article-title":"Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"83","author":"Nasu S","year":"2012","unstructured":"Nasu S, Misawa S, Sekiguchi Y, et al.. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2012, 83:476-9. 10.1136\/jnnp-2011-301706","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.010","article-title":"POEMS syndrome: diagnosis and investigative work-up","volume":"32","author":"Dispenzieri A","year":"2018","unstructured":"Dispenzieri A, Kourelis T, Buadi F. POEMS syndrome: diagnosis and investigative work-up. Hematol Oncol Clin North Am. 2018, 32:119-39. 10.1016\/j.hoc.2017.09.010","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5045\/br.2022.2022001","article-title":"Update on the POEMS syndrome","volume":"57","author":"Kim YR","year":"2022","unstructured":"Kim YR. Update on the POEMS syndrome. Blood Res. 2022, 57:S27-31. 10.5045\/br.2022.2022001","journal-title":"Blood Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato M","year":"2005","unstructured":"Scarlato M, Previtali SC, Carpo M, et al.. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain. 2005, 128:1911-20. 10.1093\/brain\/awh519","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318263c42b","article-title":"Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome","volume":"79","author":"Kanai K","year":"2012","unstructured":"Kanai K, Sawai S, Sogawa K, et al.. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology. 2012, 79:575-82. 10.1212\/WNL.0b013e318263c42b","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02659-7","article-title":"Interleukin-6 is a highly prognostic biomarker for POEMS syndrome","volume":"39","author":"Cook J","year":"2025","unstructured":"Cook J, Warsame R, Omar M, et al.. Interleukin-6 is a highly prognostic biomarker for POEMS syndrome. Leukemia. 2025, 39:2281-4. 10.1038\/s41375-025-02659-7","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11237011","article-title":"Recent advances in the treatment and supportive care of POEMS syndrome","volume":"11","author":"Bou Zerdan M","year":"2022","unstructured":"Bou Zerdan M, George TI, Bunting ST, Chaulagain CP. Recent advances in the treatment and supportive care of POEMS syndrome. J Clin Med. 2022, 11:7011. 10.3390\/jcm11237011","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum DC","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A, et al.. International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood. 2017, 129:1646-57. 10.1182\/blood-2016-10-746933","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-014-0265-8","article-title":"The role of radiotherapy in the management of POEMS syndrome","volume":"9","author":"Suh YG","year":"2014","unstructured":"Suh YG, Kim YS, Suh CO, Kim YR, Cheong JW, Kim JS, Cho J. The role of radiotherapy in the management of POEMS syndrome. Radiat Oncol. 2014, 9:265. 10.1186\/s13014-014-0265-8","journal-title":"Radiat Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0209-7","article-title":"European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias","volume":"32","author":"Gavriatopoulou M","year":"2018","unstructured":"Gavriatopoulou M, Musto P, Caers J, et al.. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias. Leukemia. 2018, 32:1883-98. 10.1038\/s41375-018-0209-7","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00540-1","article-title":"Treatment and outcomes of POEMS syndrome: changes in the past 20 years","volume":"11","author":"Yu YY","year":"2021","unstructured":"Yu YY, Gao XM, Zhao H, et al.. Treatment and outcomes of POEMS syndrome: changes in the past 20 years. Blood Cancer J. 2021, 11:145. 10.1038\/s41408-021-00540-1","journal-title":"Blood Cancer J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000796","article-title":"Comprehensive diagnosis and management of POEMS syndrome","volume":"6","author":"D'Sa S","year":"2022","unstructured":"D'Sa S, Khwaja J, Keddie S, et al.. Comprehensive diagnosis and management of POEMS syndrome. Hemasphere. 2022, 6:e796. 10.1097\/HS9.0000000000000796","journal-title":"Hemasphere"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24356","article-title":"Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience","volume":"91","author":"Kourelis TV","year":"2016","unstructured":"Kourelis TV, Buadi FK, Kumar SK, et al.. Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience. Am J Hematol. 2016, 91:585-9. 10.1002\/ajh.24356","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e5","article-title":"A multicenter analysis of clinical features and long-term outcomes of POEMS syndrome in Korea","volume":"39","author":"Kook HW","year":"2024","unstructured":"Kook HW, Jang JE, Min CK, et al.. A multicenter analysis of clinical features and long-term outcomes of POEMS syndrome in Korea. J Korean Med Sci. 2024, 39:e5. 10.3346\/jkms.2024.39.e5","journal-title":"J Korean Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456158-when-foot-drop-tells-a-bigger-story-poems-polyneuropathy-organomegaly-endocrinopathy-monoclonal-plasma-cell-disorder-and-skin-changes-syndrome-revealed-by-femoral-plasmacytoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T07:42:01Z","timestamp":1771314121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456158-when-foot-drop-tells-a-bigger-story-poems-polyneuropathy-organomegaly-endocrinopathy-monoclonal-plasma-cell-disorder-and-skin-changes-syndrome-revealed-by-femoral-plasmacytoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.103751","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,16]]}}}